Chad Mulvany, FHFMA
About the Author
Chad Mulvany, FHFMA
Latest Work
What’s new in the CARES Act Provider Relief Fund FAQs as of Aug. 17
HHS failed Aug. 17 to release guidance providers need to file reports for lost revenue and increased expenses amid COVID-19; HFMA will continue to monitor its website.
Looking beyond CMS: How to accelerate the transition to value in healthcare
HFMA's Chad Mulvany summarizes a blog on actions CMS and Congress can take to transition providers to capitated and other risk-bearing payment models.
CARES Act Provider Relief Fund FAQs undergo another update as of August 14
HFMA's Chad Mulvany recommends healthcare leaders who think their organizations qualify for Phase 2 General Distributions review the FAQs.
More independent physician practices likely to seek partners in the coming months due to financial issues caused by COVID-19
HFMA's Chad Mulvany says given the limited days cash on hand independent physician practices report having, it is likely practices will start seeking partners in the coming months, if they haven’t already.
Fewer cancer diagnoses in first weeks of the pandemic imply increased spending on cancer treatment in the future
HFMA's Chad Mulvany says good actuarial support is more important than ever for providers considering entering into risk-based models in response to the pandemic.
McKinsey & Company survey: Physician perceptions of COVID-19 risk influence referral patterns
HFMA's Chad Mulvany says these McKinsey findings illustrate the importance of involving physicians in the development and execution of checklists used to safely reopen clinics and restart non-emergent procedures.
U.S. Department of Health & Human Services updates CARES Act Provider Relief Fund FAQs as of July 30
HHS says the CARES Act Provider Relief Funds need to be used by July 31, 2021, but Chad Mulvany says operationally, funds likely need to be spent by June 30, 2021, so providers can capture expenses and lost revenue in reports due to HHS July 31.
What to expect from President Trump’s recent executive orders on drug prices
HFMA's Chad Mulvany says the Most Favored Nation pricing executive order faces long odds of becoming an enforced policy because it faces significant opposition from three of the most influential lobbies in Washington, D.C.
Healthcare consumers want information personalized to their situation from health plans
HFMA's Chad Mulvany says patients and consumers need information that’s relevant to their specific clinical situation and out-of-pocket costs for price and quality information to be meaningful.
Congress may not provide a surprise bill fix prior to the election, but patients may find HFMA’s consumer guide useful
Given Congress is unlikely to provide a surprise bill fix prior to the election, Chad Mulvany suggests hospitals provide patients with HFMA's consumer guide on avoiding surprise bills to learn what questions to ask prior to any scheduled services.